Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single nucleotide polymorphisms in breast cancer.

Asta Försti1, Sabrina Angelini, Fabiola Festa

  • 1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. a.foersti@dkfz.de

Oncology Reports
|March 11, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does lung adenocarcinoma subtyping offer clinical benefits?-a retrospective population-based cohort study from Sweden.

Annals of translational medicine·2026
Same author

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same author

GWAS meta-analysis provides new insights into uveal melanoma risk.

British journal of cancer·2026
Same author

Familial risks in prostate cancer between brothers and half-brothers as clues to germline genetic and environmental causes.

Familial cancer·2026
Same author

Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics.

European urology open science·2026
Same author

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.

International journal of cancer·2026

This study investigated low-penetrance genes for breast cancer (BC) risk. Researchers found no significant associations for common genetic variants, suggesting they do not substantially impact BC heritability.

Area of Science:

  • Genetics
  • Oncology
  • Epidemiology

Background:

  • Heritable breast cancer (BC) risk is primarily linked to a few high-penetrance genes.
  • The role of low-penetrance genes in BC susceptibility remains largely unexplored.
  • Identifying novel genetic factors could improve BC risk assessment and prevention strategies.

Purpose of the Study:

  • To investigate the association between common genetic polymorphisms in DNA repair genes, MTHFR, and cyclin D1 with breast cancer risk.
  • To evaluate potential low-penetrance genetic factors contributing to breast cancer susceptibility.
  • To validate findings across two distinct populations (Finnish and Polish) to ensure robustness.

Main Methods:

  • An association study was conducted using 223 Finnish unselected BC patients and 172 Polish familial BC cases, with local healthy controls.

Related Experiment Videos

  • Genotyping of single nucleotide polymorphisms (SNPs) was performed for NBS1, XPC, XPD, XRCC1, XRCC3, MTHFR, and cyclin D1 genes.
  • Odds ratios (ORs) were calculated to assess the association of each SNP with BC risk relative to the wild-type genotype.

    • Main Results:

    • Initial analysis in the Finnish cohort suggested potential associations for XPC exon 15, XPD exon 10, and XRCC3 exon 7 (borderline significance) with BC risk.
    • These associations could not be replicated in the Polish cohort.
    • Deviations from Hardy-Weinberg Equilibrium (HWE) in control groups for both populations raised concerns about potential artifacts, particularly for XPC and XPD findings.

    Conclusions:

    • The study found no statistically significant association between the tested common polymorphisms and breast cancer risk within the given statistical power.
    • Replication failures and potential population-specific artifacts (HWE deviations) limit the interpretation of initial positive findings.
    • Further research with larger sample sizes and diverse populations is needed to definitively assess the role of low-penetrance genes in breast cancer etiology.